Eric M. Dube, CEO: Travere Therapeutics TVTX Planned sale · Filed 09/17

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Eric M. DubeCEO
Planned sale date: 26/09/17
Filed: 26/09/17

More to sell after $18.4M in 3 months

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 08/18~10/17

Eric M. Dube's recent trades

Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$12.2M
195,841 sh
$12.2M
Filed 09/16
Traded 09/16
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.3M
95,666 sh
$6.3M
Filed 09/15
Traded 09/15
Eric M. DubeCEO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06
Eric M. DubeCEO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$2.3M
56,815 sh
$2.3M
Filed 04/15
Traded 04/15

Eric M. Dube, CEO — plans to sell 108,493 sh of Travere Therapeutics TVTX · $6.9M · around 09/17 · 10b5-1 plan | Whalegun